Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial
about
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with ElectrocardiogramsPast and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventionsPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic studyThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT intervalMalaria: an update on current chemotherapy.Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquinePotent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations.Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study.A deep sequencing tool for partitioning clearance rates following antimalarial treatment in polyclonal infections.Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to ThailandPiperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.Antimalarial Drug Resistance: A Threat to Malaria Elimination.Maximizing research study effectiveness in malaria elimination settings: a mixed methods study to capture the experiences of field-based staff.Longitudinal Pooled Deep Sequencing of the Plasmodium vivax K12 Kelch Gene in Cambodia Reveals a Lack of Selection by Artemisinin.Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysisMolecular assays for antimalarial drug resistance surveillance: A target product profile
P2860
Q28552793-553B25FA-48D8-4A44-898D-9A99D8B701E4Q28646971-70C09172-D1CE-4109-96A1-C136BC55702DQ30240158-A76F809B-1B4B-4443-ABAA-69205F987B2EQ30389796-6A9D4D3F-6B1D-489E-A0A9-9EA73D9B1859Q33655603-64234043-0016-435E-8114-AF95EB1DC00CQ34298916-BCE9A61D-3FB8-448E-9D23-174DE531F2CEQ34298973-A67A5AFB-920A-4FA4-A2DD-732BA8E96E9CQ34433106-0C8D8833-8AB2-4779-861F-D16E6DF13F2EQ34646141-959081D2-C57A-46AE-85C9-276F2B2469BFQ34694931-FB1F5338-1DB5-4778-A313-EB46E91FE6F0Q35701564-CE72195F-8897-4ECB-8D04-AE450013E37FQ35859975-124A8D45-DDC3-439A-851F-D9DAC59EC713Q35875707-8CC660E8-7D62-4AC6-95CE-9323630E1601Q35993493-081961D9-7BC5-4ADB-BCC4-5FB7E8297D81Q36108352-F1B48FE6-F572-488A-9925-77FF520A7471Q36446343-B1074473-BC35-4329-946C-FEB91F369D21Q36579251-A6F5FE75-851F-46B2-97A0-D243FBE6DE0BQ36644858-A89CB909-5208-4832-A321-EE62E334E9C3Q37358872-A34A2375-5C73-472D-A37F-86A92BFCE503Q38380902-D27B66D4-87F8-4305-93B4-6C85E2C29329Q38558100-0EDD51D2-5D8A-4555-8DFA-7D3AF33D52E3Q39176615-2DA3E80C-9C0C-45E8-9ADB-16BF4DB05488Q40053255-E50DEAC2-B2A1-4FE6-9CD3-DD4E0F1CC334Q40472898-76BC2093-7C8F-402E-9253-EDCCDBBAACC1Q46405195-CC83CA6C-E6AE-4E20-B583-21A748EB47C5Q56352635-83A19670-1218-4287-B5F4-6AFB6717A873Q57154187-2780720E-0FE4-42F2-AB8D-57F9AFE1EC23
P2860
Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy of two versus three-d ...... an open-label randomized trial
@ast
Efficacy of two versus three-d ...... an open-label randomized trial
@en
Efficacy of two versus three-d ...... an open-label randomized trial
@nl
type
label
Efficacy of two versus three-d ...... an open-label randomized trial
@ast
Efficacy of two versus three-d ...... an open-label randomized trial
@en
Efficacy of two versus three-d ...... an open-label randomized trial
@nl
prefLabel
Efficacy of two versus three-d ...... an open-label randomized trial
@ast
Efficacy of two versus three-d ...... an open-label randomized trial
@en
Efficacy of two versus three-d ...... an open-label randomized trial
@nl
P2093
P2860
P3181
P1433
P1476
Efficacy of two versus three-d ...... an open-label randomized trial
@en
P2093
Chanthap Lon
Char Meng Chuor
Charlotte Lanteri
Darapiseth Sea
David Saunders
Delia Bethell
Douglas S Walsh
Douglas Tang
Jessica E Manning
Jessica Lin
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0093138
P407
P577
2014-01-01T00:00:00Z